Search - tctmd.com

Displaying 1 - 6 of 6

Sort: Relevancy | Date

News Conference News TCT 2025

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

Michael O'Riordan

October 26, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Conference News TCT 2022

SCAAR Registry Delves Into Left Main Revascularization Outcomes

Michael O'Riordan

September 19, 2022

News Conference News TCT 2019

EXCEL at 5 Years: PCI for Left Main CAD Still Noninferior to CABG

Marcus A. Banks

September 28, 2019

News Conference News TCT 2017

No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS

Michael O'Riordan

October 30, 2017

Presentation TCT 2012

Drug Eluting Stents in the Treatment of Isolated Proximal LAD Disease are Associated with Similar Outcomes Compared to Minimally Invasive LIMA Grafts

Presenter: Daniel A. Jones, Krishnaraj S. Rathod, Sean M. Gallagher, Zia Buckhoree, Mohammed Akhtar, Ajay K. Jain, Charles Knight, Anthony Mathur, Rakesh Uppal, Andrew Wragg

January 03, 2012

Advertisement

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

What’s Going to Be Hot at TCT 2025

SCAAR Registry Delves Into Left Main Revascularization Outcomes

EXCEL at 5 Years: PCI for Left Main CAD Still Noninferior to CABG

No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS

Drug Eluting Stents in the Treatment of Isolated Proximal LAD Disease are Associated with Similar Outcomes Compared to Minimally Invasive LIMA Grafts

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content